This month’s boardroom activity across biotech, diagnostics, CROs, and digital health companies highlights a strategic push for scientific excellence, commercial acumen, and global leadersh
One area in which March proved to be a busy month was in Board appointments, where both Boards of Directors and Advisory Boards saw a number of interesting additions.
